The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria.

activated complement factor 5 (C5a) chronic spontaneous urticaria (CSU) coagulation factors complement components endothelial cells leukocytes mast cells protease activated receptor (PAR)

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
12 07 2021
Historique:
received: 31 05 2021
revised: 09 07 2021
accepted: 09 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 27 10 2021
Statut: epublish

Résumé

Chronic spontaneous urticaria (CSU) is a common skin disorder characterized by an almost daily recurrence of wheal and flare with itch for more than 6 weeks, in association with the release of stored inflammatory mediators, such as histamine, from skin mast cells and/or peripheral basophils. The involvement of the extrinsic coagulation cascade triggered by tissue factor (TF) and complement factors, such as C3a and C5a, has been implied in the pathogenesis of CSU. However, it has been unclear how the TF-triggered coagulation pathway and complement factors induce the activation of skin mast cells and peripheral basophils in patients with CSU. In this review, we focus on the role of vascular endothelial cells, leukocytes, extrinsic coagulation factors and complement components on TF-induced activation of skin mast cells and peripheral basophils followed by the edema formation clinically recognized as urticaria. These findings suggest that medications targeting activated coagulation factors and/or complement components may represent new and effective treatments for patients with severe and refractory CSU.

Identifiants

pubmed: 34359930
pii: cells10071759
doi: 10.3390/cells10071759
pmc: PMC8306267
pii:
doi:

Substances chimiques

Receptors, Proteinase-Activated 0
Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Allergy Asthma Immunol Res. 2019 Jul;11(4):470-481
pubmed: 31172716
J Immunol Res. 2019 Dec 7;2019:4202145
pubmed: 31886301
Thromb Res. 2010 Apr;125 Suppl 1:S31-4
pubmed: 20149415
Br J Dermatol. 2005 Jul;153(1):216-7
pubmed: 16029359
Int J Mol Sci. 2018 Dec 22;20(1):
pubmed: 30583496
Clin Exp Allergy. 2017 Jan;47(1):19-36
pubmed: 27926978
Thromb Haemost. 1997 Feb;77(2):394-8
pubmed: 9157602
J Allergy Clin Immunol. 2006 May;117(5):1113-7
pubmed: 16675340
Am J Respir Cell Mol Biol. 1995 Jun;12(6):691-6
pubmed: 7766432
J Allergy Clin Immunol. 2016 Sep;138(3):700-710
pubmed: 27448446
Allergol Int. 2015 Jan;64(1):96-8
pubmed: 25572563
Acta Pharmacol Sin. 2005 May;26(5):568-74
pubmed: 15842775
Int Arch Allergy Immunol. 2013;161 Suppl 2:154-8
pubmed: 23711867
J Allergy Clin Immunol. 2014 Sep;134(3):622-633.e9
pubmed: 24954276
Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):387-96
pubmed: 15349038
J Invest Dermatol. 2006 Apr;126(4):746-55
pubmed: 16470180
J Investig Allergol Clin Immunol. 2016 Oct;26(5):310-313
pubmed: 27763857
Int Arch Allergy Immunol. 2009;148(2):170-4
pubmed: 18802362
J Nippon Med Sch. 2017;84(4):148-159
pubmed: 28978894
J Allergy Clin Immunol. 2021 Mar;147(3):1101-1104.e7
pubmed: 32888945
Allergy. 2011 Dec;66(12):1538-45
pubmed: 21906078
Clin Exp Immunol. 2020 Jun;200(3):242-249
pubmed: 32115683
J Allergy Clin Immunol. 2014 Jan;133(1):217-24.e1-3
pubmed: 23768573
J Dermatol. 2020 Nov;47(11):1293-1300
pubmed: 32748974
J Allergy Clin Immunol. 2018 Mar;141(3):1115-1118.e7
pubmed: 28859973
J Immunol. 2010 Nov 1;185(9):5628-36
pubmed: 20870944
Indian Dermatol Online J. 2016 Jan-Feb;7(1):6-11
pubmed: 26955580
J Dtsch Dermatol Ges. 2015 May;13(5):419-28
pubmed: 25918085
Clin Exp Allergy. 2000 Aug;30(8):1161-5
pubmed: 10931124
Helicobacter. 2019 Dec;24(6):e12661
pubmed: 31523897
Ann Allergy Asthma Immunol. 2020 Jan;124(1):2-12
pubmed: 31446134
Mol Immunol. 2008 Jun;45(11):3125-32
pubmed: 18452991
Allergy. 2020 Apr;75(4):971-974
pubmed: 31715000
Exp Dermatol. 2010 Feb;19(2):117-22
pubmed: 19889021
Allergy. 2018 Nov;73(11):2256-2260
pubmed: 29987892
Clin Exp Allergy. 2009 Jun;39(6):777-87
pubmed: 19400905
Blood. 2007 Feb 1;109(3):995-1002
pubmed: 17003379
N Engl J Med. 2019 Oct 3;381(14):1321-1332
pubmed: 31577874
N Engl J Med. 1993 Jun 3;328(22):1599-604
pubmed: 7683772
Semin Nephrol. 2013 Nov;33(6):479-92
pubmed: 24161035
Clin Exp Allergy. 2005 Dec;35(12):1599-607
pubmed: 16393326
Clin Chem Lab Med. 2014 Jun;52(6):e115-8
pubmed: 24406285
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2195-2208
pubmed: 33823316
J Allergy Clin Immunol. 2018 Sep;142(3):876-882
pubmed: 29208545
J Immunol. 2003 Sep 1;171(5):2631-6
pubmed: 12928416
Asian Pac J Allergy Immunol. 2013 Mar;31(1):43-50
pubmed: 23517393
Int J Inflam. 2011;2011:367284
pubmed: 21941675
Allergy. 2010 May;65(5):649-56
pubmed: 19845571
Nat Med. 2006 Jun;12(6):682-7
pubmed: 16715088
Bull Soc Fr Dermatol Syphiligr. 1952 May-Jun;59(3):286-7
pubmed: 12987986

Auteurs

Yuhki Yanase (Y)

Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Shunsuke Takahagi (S)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

Koichiro Ozawa (K)

Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Michihiro Hide (M)

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Department of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima 730-8518, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH